Viewpoint: DNA data ‘rat race’ bringing down costs of precision medicine but perils of security risks escalate

Viewpoint: DNA data ‘rat race’ bringing down costs of precision medicine but perils of security risks escalate

Publication date: Apr 13, 2019

It is said that this is the best of times for direct to consumer (DTC) genetic testing companies, human disease genomics, and the launch of genomic data marketplaces.

While a plethora of risk factors will likely determine the reality of personalized medicine, the truth of the emerging DNA data race necessitates an understanding of the security risks originating from genetic testing, genomic footprints, genomic databases, genomic medicine, DNA biobanks, and genomic marketplaces.

Concepts Keywords
Biobanks Precision medicine
Genetic Biobank
Genetic Testing Genomics
Genomic Medicine Genetic testing
Genomics Personalized medicine
Personalized Medicine Emerging technologies
Precision Medicine Genomics
Medical genetics
Medical tests
Applied genetics
Clinical medicine
Medicine
Branches of biology
Causal disease

Semantics

Type Source Name
gene UNIPROT AMACR
gene UNIPROT BEST1
disease MESH development
disease MESH risk factors
gene UNIPROT SLC35G1

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *